Only one of four patients with familial hypercholesterolaemia reach cholesterol treatment goals in primary prevention

J Intern Med. 2004 Aug;256(2):176-7. doi: 10.1111/j.1365-2796.2004.01358.x.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Cholesterol, LDL / blood*
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
  • Hyperlipoproteinemia Type II / blood*
  • Hyperlipoproteinemia Type II / psychology
  • Hyperlipoproteinemia Type II / therapy
  • Patient Compliance
  • Primary Health Care
  • Treatment Failure

Substances

  • Cholesterol, LDL
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors